Check out the companies that hit the headlines on Tuesday after the bell:
Atlassian – The shares of the Australian software company rose 1% on the revised sales forecast for the third fiscal quarter. Atlassian now expects sales between $ 566 million and $ 572 million. Analysts polled by FactSet previously forecast revenue of $ 487.2 million for the company’s third quarter. The new forecast is also above Atlassian’s previous revenue forecast for the quarter.
Stitch Fix – Shares in Personal Styling Service were down 3.2% after the company announced that founder and CEO Katrina Lake would become managing director and Elizabeth Spaulding would take over as CEO, effective August 1.
Endo International – The pharmaceutical company’s shares rose slightly after the company announced that promising Phase 3 data on a cellulite treatment was published in the official journal of the American Society of Dermatologic Surgery. The data showed that the treatment produced a clinically meaningful improvement in the incidence of moderate to severe cellulite in the buttocks of adult women compared to placebo.
Amicus Therapeutics – The biopharmaceutical company’s shares rose 3% after Cantor Fitzgerald analysts upgraded the stock from neutral to overweight, citing promising gene therapy results.
Discovery – Discovery’s Class A and C shares fell 3.8% and 5.1%, respectively, after CNBC’s David Faber reported that Credit Suisse continued to run down positions in the media company amid the Archegos Capital Management explosion. Citing dealers, Credit Suisse sold 19 million Class A shares in the media company and 22 million Class C shares.